ABG Analytics logo
Get updates

Biogen Inc (NASDAQ: BIIB)

DRUGS - Biotechnology
Sector: Health Care
Stock price data as of 09/20/2019
Closing price: 238.79
Support price level: $225.16
Resistance price level: $241.74
Relative strength index (14-day RSI) 74.4
Beta 1.26
  • With a -29.5 percent return in the past year, this stock is among the worst 10 percent of performers in the S&P-100.

  • BIIB is one of this week's most volatile stocks in the S&P-100 with an estimated annualized standard deviation of 36.6%.

  • Volatility is forecast to fall over the next month.

  • With RSI > 70, BIIB is overbought. Odds slightly favor a short-term price reversal.

Low High Price as % of Range
$216.71 $355.60 19.6%
200 day 50 day 20 day 10 day
$263.75 $232.47 $228.45 $235.23
(Annualized standard deviation)
Historical
(5 year)
Last month Current estimate Next month forecast
36.7% 36.1% 36.6% 36.8%
There is an estimated 5% probability that the stock price of Biogen Inc will fall by more than:
  • 9.9% in the next week.

  • 20.8% in the next month.

  • 79.3% in the next year.